Evaluation of new medicines in Spain and comparison with other European countries
Objective To compare the use of health technology assessment (HTA) as a tool to support pricing and reimbursement (P&R) of new medicines in Spain with England, Sweden, France and Germany. Method For each country, the literature is used to identify the purpose and timing of the P&R decision, the HTA and decision-making procedures used to…